BOSTON SCIENTIFIC CORP (BSX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 7B 14B 21B FY07: 8.4B FY08: 8.1B FY09: 8.2B FY10: 7.8B FY11: 7.6B FY12: 7B FY13: 7.1B FY14: 7.5B FY15: 8.1B FY16: 8.4B FY17: 9B FY18: 9.8B FY19: 10.7B FY20: 9.9B FY21: 11.9B FY22: 12.7B FY23: 14.2B FY24: 16.7B FY25: 20.1B FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

0 5B 10B 15B FY07: 6B FY08: 5.6B FY09: 5.6B FY10: 5.2B FY11: 5B FY12: 4.9B FY13: 5B FY14: 5.2B FY15: 5.3B FY16: 6B FY17: 6.5B FY18: 7B FY19: 7.6B FY20: 6.4B FY21: 8.2B FY22: 8.7B FY23: 9.9B FY24: 11.5B FY25: 13.9B FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Income Annual

-4.5B -3B -1.5B 0 1.5B 3B 4.5B FY07: -14M FY08: -1.5B FY09: -894M FY10: -656M FY11: 904M FY12: -3.9B FY13: 120M FY14: -301M FY15: -283M FY16: 447M FY17: 1.3B FY18: 1.5B FY19: 1.5B FY20: -80M FY21: 1.2B FY22: 1.6B FY23: 2.3B FY24: 2.6B FY25: 3.6B FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-6B -4B -2B 0 2B 4B 6B FY07: -495M FY08: -2B FY09: -1B FY10: -1.1B FY11: 441M FY12: -4.1B FY13: -121M FY14: -119M FY15: -239M FY16: 347M FY17: 104M FY18: 1.7B FY19: 4.7B FY20: -82M FY21: 1B FY22: 698M FY23: 1.6B FY24: 1.8B FY25: 2.9B FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 2.5B 5B 7.5B FY07: 2.3B FY08: 2.5B FY09: 2.6B FY10: 2.6B FY11: 2.7B FY12: 2.3B FY13: 2.2B FY14: 2.2B FY15: 2.2B FY16: 2.4B FY17: 2.6B FY18: 2.8B FY19: 3.1B FY20: 3.5B FY21: 3.7B FY22: 4B FY23: 4.3B FY24: 5.3B FY25: 6.2B FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Cash Flow Annual

0 2B 4B 6B FY07: 934M FY08: 1.2B FY09: 835M FY10: 325M FY11: 1B FY12: 1.3B FY13: 1.1B FY14: 1.3B FY15: 691M FY16: 1.2B FY17: 1.4B FY18: 310M FY19: 1.8B FY20: 1.5B FY21: 1.9B FY22: 1.5B FY23: 2.5B FY24: 3.4B FY25: 4.5B FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-1.5B 0 1.5B 3B 4.5B FY07: 571M FY08: 854M FY09: 523M FY10: 53M FY11: 704M FY12: 1.1B FY13: 865M FY14: 1B FY15: 444M FY16: 806M FY17: 1.1B FY18: -6M FY19: 1.4B FY20: 1.1B FY21: 1.3B FY22: 938M FY23: 1.8B FY24: 2.6B FY25: 3.7B FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 600M 1.2B 1.8B FY07: 1.5B FY08: 1.5B FY09: 1.5B FY10: 1.5B FY11: 1.5B FY12: 1.4B FY13: 1.3B FY14: 1.3B FY15: 1.3B FY16: 1.4B FY17: 1.4B FY18: 1.4B FY19: 1.4B FY20: 1.4B FY21: 1.4B FY22: 1.4B FY23: 1.5B FY24: 1.5B FY25: 1.5B FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q4 '08: -1.36 Q1 '09: -1.58 Q2 '09: -1.55 Q3 '09: -1.57 Q4 '09: -0.68 Q1 '10: -1.72 Q2 '10: -1.76 Q3 '10: -1.58 Q4 '10: -0.72 Q1 '11: 0.36 Q2 '11: 0.40 Q3 '11: 0.37 Q4 '11: 0.29 Q1 '12: 0.34 Q2 '12: -2.27 Q3 '12: -2.84 Q4 '12: -2.89 Q1 '13: -3.23 Q2 '13: -0.62 Q3 '13: -0.14 Q4 '13: -0.09 Q1 '14: 0.27 Q2 '14: 0.17 Q3 '14: 0.20 Q4 '15: -0.18 Q1 '16: -0.03 Q2 '16: -0.26 Q3 '16: 0.06 Q4 '16: 0.26 Q1 '17: 0.32 Q2 '17: 0.58 Q3 '17: 0.61 Q4 '18: 1.19 Q1 '19: 1.28 Q2 '19: 0.99 Q3 '19: 0.77 Q4 '19: 3.33 Q1 '20: 3.04 Q2 '20: 2.82 Q3 '20: 2.61 Q4 '20: -0.08 Q1 '21: 0.14 Q2 '21: 0.37 Q3 '21: 0.77 Q4 '21: 0.69 Q1 '22: 0.53 Q2 '22: 0.58 Q3 '22: 0.42 Q4 '22: 0.45 Q1 '23: 0.59 Q2 '23: 0.60 Q3 '23: 0.82 Q4 '23: 1.07 Q1 '24: 1.19 Q2 '24: 1.23 Q3 '24: 1.21 Q4 '24: 1.25 Q1 '25: 1.37 Q2 '25: 1.68 Q3 '25: 1.87 Q4 '25: 1.94 Q1 '26: 2.39 Q2 '26: 2.47 Q2 '10 Q2 '12 Q2 '14 Q2 '17 Q2 '20 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.